- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
有加速上涨趋势。
- 长期趋势：
已有566家主力机构披露2025-12-31报告期持股数据，持仓量总计12.75亿股，占流通A股71.91%
- 波段诊断：
-
技术面诊股
平均成本
近期的平均成本为52.78元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"52.78","date":1777967507,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，明显跑输行业平均水平。
[{"date":"2026.05.06","stock":"-0.75","trade":"-0.14","ind":"2.33"},{"date":"2026.04.30","stock":"0.00","trade":"0.43","ind":"-0.09"},{"date":"2026.04.29","stock":"-0.38","trade":"0.63","ind":"1.96"},{"date":"2026.04.28","stock":"1.01","trade":"0.26","ind":"-1.10"},{"date":"2026.04.27","stock":"-0.26","trade":"-0.18","ind":"0.37"},{"date":"2026.04.24","stock":"0.28","trade":"-0.04","ind":"-0.69"},{"date":"2026.04.23","stock":"-0.37","trade":"-0.87","ind":"-0.88"},{"date":"2026.04.22","stock":"-1.05","trade":"0.13","ind":"1.30"},{"date":"2026.04.21","stock":"0.11","trade":"-0.57","ind":"0.10"},{"date":"2026.04.20","stock":"-0.52","trade":"0.15","ind":"0.55"},{"date":"2026.04.17","stock":"-0.41","trade":"-1.52","ind":"0.60"},{"date":"2026.04.16","stock":"-0.36","trade":"-0.13","ind":"2.05"},{"date":"2026.04.15","stock":"1.22","trade":"2.03","ind":"-0.97"},{"date":"2026.04.14","stock":"0.58","trade":"0.36","ind":"1.61"},{"date":"2026.04.13","stock":"-0.35","trade":"-1.82","ind":"0.69"},{"date":"2026.04.10","stock":"-0.33","trade":"0.01","ind":"2.24"},{"date":"2026.04.09","stock":"-1.50","trade":"-1.54","ind":"-0.33"},{"date":"2026.04.08","stock":"0.05","trade":"0.62","ind":"4.79"},{"date":"2026.04.07","stock":"-0.97","trade":"0.87","ind":"0.36"},{"date":"2026.04.03","stock":"-0.56","trade":"-2.39","ind":"-0.99"},{"date":"2026.04.02","stock":"2.18","trade":"0.62","ind":"-1.60"}]
云南白药,深证成指,中药指数
压力支撑
该股压力位为52.79元，支撑位为52.52元。
[{"text":"\u538b\u529b\u4f4d","value":"52.79","date":1777996800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"52.52","date":1777996800,"color":"0x0b52a1"}]
多空趋势
多头行情中，并且有加速上涨趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.1资金面打败了8%的股票
主力控盘前10的股票
行业资金
中药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：05月06日 20:30
| 机构今日流向(万元) | -985.90 | 机构5日流向(万元) | -1631.08 |
| 机构10日流向(万元) | -6965.54 | 机构20日流向(万元) | -19291.93 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量减少2482.99万股，其中基金净减仓196家，主力净减仓133家，请投资者中长期谨慎为宜。
截止2025-12-31，共566家主力机构（基金557家，一般法人7家，券商集合理财1家，保险公司1家），持仓量总计127487.09万股，占流通A股71.91%
其中，基金持仓与2025-06-30相比：
增仓：95家 ，增持 816.82万股
减仓：291家 ，减持 1422.12万股
新出现在主力名单中：135家 ，持有8492.5万股
从主力名单中消失：268家 ，原持有2575.93万股
其中，基金持仓与2025-06-30相比：
增仓：95家 ，增持 816.82万股
减仓：291家 ，减持 1422.12万股
新出现在主力名单中：135家 ，持有8492.5万股
从主力名单中消失：268家 ，原持有2575.93万股
消息面诊股
诊断结果：5.7消息面打败了9%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 生物医药行业：创新提速、战略升级，整体企稳、结构分
2026-05-06 - 云南白药：4月30日获融资买入4058.69万元
2026-05-06 - 白药健康礼 双廊遇见你——云南白药生活+大理新店启
2026-05-05 - 云南白药集团：“数”上发力蹚出中医药行业智能化升级
2026-05-04 - 云南白药一季度营业收入116.03亿元，同比增长7
2026-05-03 - 大分化：昔日“亏损王”最高飙涨115%，“药中茅台
2026-05-02 - 机构评级|中金公司给予云南白药“跑赢行业”评级
2026-05-01 - 云南白药：云南白药应急包系列产品依托云南白药百年药
2026-04-30 - 云南白药：公司未采购PVP材料
2026-04-30 - 云南白药：INR101诊断核药项目完成Ⅲ期临床29
2026-04-30
消息列表
| 一般消息 | 重大事项 | 关联交易 | 2026-04-22 |
| 一般消息 | 股东大会 | 年度股东大会 | 2026-04-01 |
| 利好 | 分红转增 | 10派15.83元(含税) | 2026-04-01 |
| 一般消息 | 重大事项 | 关联交易 | 2026-04-01 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-03-25 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-02-26 |
| 一般消息 | 高管变动 | 达到法定退休年龄 | 2026-02-10 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-02-04 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-12-31 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-11-10 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-10-29 |
| 利好 | 分红转增 | 10派10.19元(含税) | 2025-08-30 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-05-14 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 4条 | 0条 | 4条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：6.1行业面打败了75%的股票
中药行业最新资金流向
近10日来该行业走势不明显，跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑输大盘。
[{"date":"2026.05.06","price":"2.33","value":"-0.14"},{"date":"2026.04.30","price":"-0.09","value":"0.43"},{"date":"2026.04.29","price":"1.96","value":"0.63"},{"date":"2026.04.28","price":"-1.10","value":"0.26"},{"date":"2026.04.27","price":"0.37","value":"-0.18"},{"date":"2026.04.24","price":"-0.69","value":"-0.04"},{"date":"2026.04.23","price":"-0.88","value":"-0.87"},{"date":"2026.04.22","price":"1.30","value":"0.13"},{"date":"2026.04.21","price":"0.10","value":"-0.57"},{"date":"2026.04.20","price":"0.55","value":"0.15"},{"date":"2026.04.17","price":"0.60","value":"-1.52"},{"date":"2026.04.16","price":"2.05","value":"-0.13"},{"date":"2026.04.15","price":"-0.97","value":"2.03"},{"date":"2026.04.14","price":"1.61","value":"0.36"},{"date":"2026.04.13","price":"0.69","value":"-1.82"},{"date":"2026.04.10","price":"2.24","value":"0.01"},{"date":"2026.04.09","price":"-0.33","value":"-1.54"},{"date":"2026.04.08","price":"4.79","value":"0.62"},{"date":"2026.04.07","price":"0.36","value":"0.87"},{"date":"2026.04.03","price":"-0.99","value":"-2.39"},{"date":"2026.04.02","price":"-1.60","value":"0.62"}]
深证成指,中药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 康惠股份 | 41.87% | 7.85% | 5.5分 |
| 2 | 沃华医药 | 8.66% | -1.99% | 5.2分 |
| 3 | 吉林敖东 | 7.28% | 7.04% | 5.6分 |
| 4 | 葵花药业 | 7.26% | 11.48% | 5.8分 |
| 5 | *ST香雪 | 6.05% | 2.58% | 5.0分 |
| 6 | 华神科技 | 5.66% | 15.17% | 6.3分 |
| 8 | 维康药业 | 4.98% | 13.35% | 5.2分 |
| 10 | 天士力 | 4.13% | 3.42% | 6.1分 |
| 12 | 恩威医药 | 2.69% | 1.57% | 5.5分 |
| 14 | 汉森制药 | 2.16% | 10.25% | 6.0分 |
| 16 | 益盛药业 | 0.97% | 8.05% | 6.8分 |
| 18 | 马应龙 | 0.39% | 2.58% | 6.2分 |
| 20 | 桂林三金 | -0.21% | 4.29% | 5.7分 |
| 22 | 信邦制药 | -0.59% | 6.65% | 5.9分 |
| 24 | 康恩贝 | -1.11% | -1.77% | 5.3分 |
| 26 | 九芝堂 | -1.44% | -2.74% | 5.6分 |
| 28 | 以岭药业 | -1.44% | 2.46% | 6.0分 |
| 30 | 白云山 | -1.90% | 0.89% | 5.5分 |
| 32 | 方盛制药 | -2.57% | 4.36% | 6.7分 |
| 34 | 步长制药 | -3.15% | -0.61% | 4.5分 |
| 36 | 仁和药业 | -3.40% | 2.52% | 4.9分 |
| 38 | - | -3.87% | 2.55% | 分 |
| 40 | 上海凯宝 | -3.95% | 0.86% | 5.1分 |
| 42 | 云南白药 | -4.62% | -0.38% | 5.3分 |
| 44 | 康缘药业 | -5.09% | -5.49% | 4.4分 |
| 46 | 佛慈制药 | -6.50% | 3.09% | 5.5分 |
| 48 | 红日药业 | -6.78% | 2.69% | 5.1分 |
| 50 | 振东制药 | -6.97% | 3.98% | 5.2分 |
| 52 | 古汉医药 | -7.10% | 0.82% | 5.8分 |
| 54 | 健民集团 | -7.45% | -1.37% | 5.3分 |
| 56 | ST葫芦娃 | -8.13% | -1.80% | 4.0分 |
| 58 | 太龙药业 | -9.10% | -4.50% | 4.5分 |
| 60 | 华润三九 | -10.62% | -5.12% | 5.4分 |
| 62 | 盘龙药业 | -11.35% | 0.36% | 4.3分 |
| 64 | 益佰制药 | -15.21% | -6.00% | 4.2分 |
| 66 | ST万邦 | -18.46% | -3.22% | 5.8分 |
| 68 | ST嘉应 | -29.12% | -24.80% | 4.8分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2026-03-31 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 9/107 ， 59/107。
[{"date":"2026-03-31","value":"4.96","vol":"2.21"},{"date":"2025-12-31","value":"13.07","vol":"-2.33"},{"date":"2025-09-30","value":"12.16","vol":"4.81"},{"date":"2025-06-30","value":"9.17","vol":"4.04"},{"date":"2025-03-31","value":"4.86","vol":"2.25"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
4.96 | 13.07 | 12.16 | 9.17 | 4.86 |
| 行业(%) | 2.21 | -2.33 | 4.81 | 4.04 | 2.25 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"30.63","vol":"55.05"},{"date":"2025-12-31","value":"29.51","vol":"52.85"},{"date":"2025-09-30","value":"30.06","vol":"53.26"},{"date":"2025-06-30","value":"30.86","vol":"53.79"},{"date":"2025-03-31","value":"31.55","vol":"54.43"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
30.63 | 29.51 | 30.06 | 30.86 | 31.55 |
| 行业(%) | 55.05 | 52.85 | 53.26 | 53.79 | 54.43 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 16/107 ， 32/107。
[{"date":"2026-03-31","value":"7.02","vol":"-5.58"},{"date":"2025-12-31","value":"2.88","vol":"-6.76"},{"date":"2025-09-30","value":"2.47","vol":"-7.81"},{"date":"2025-06-30","value":"3.92","vol":"-7.74"},{"date":"2025-03-31","value":"0.62","vol":"-7.31"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
7.02 | 2.88 | 2.47 | 3.92 | 0.62 |
| 行业(%) | -5.58 | -6.76 | -7.81 | -7.74 | -7.31 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"5.31","vol":"1.06"},{"date":"2025-12-31","value":"8.51","vol":"-80.25"},{"date":"2025-09-30","value":"10.41","vol":"-2.50"},{"date":"2025-06-30","value":"13.93","vol":"2.58"},{"date":"2025-03-31","value":"13.67","vol":"-37.35"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
5.31 | 8.51 | 10.41 | 13.93 | 13.67 |
| 行业(%) | 1.06 | -80.25 | -2.50 | 2.58 | -37.35 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 3/107 ， 5/107。
[{"date":"2026-03-31","value":"0.21","vol":"0.12"},{"date":"2025-12-31","value":"0.77","vol":"0.47"},{"date":"2025-09-30","value":"0.58","vol":"0.35"},{"date":"2025-06-30","value":"0.40","vol":"0.24"},{"date":"2025-03-31","value":"0.20","vol":"0.13"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.21 | 0.77 | 0.58 | 0.40 | 0.20 |
| 行业(次) | 0.12 | 0.47 | 0.35 | 0.24 | 0.13 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"1.30","vol":"0.59"},{"date":"2025-12-31","value":"4.64","vol":"2.34"},{"date":"2025-09-30","value":"3.55","vol":"1.72"},{"date":"2025-06-30","value":"2.42","vol":"1.17"},{"date":"2025-03-31","value":"1.21","vol":"0.60"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.30 | 4.64 | 3.55 | 2.42 | 1.21 |
| 行业(次) | 0.59 | 2.34 | 1.72 | 1.17 | 0.60 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2026-03-31","value":"7.15","vol":"5.83"},{"date":"2025-12-31","value":"1.36","vol":"30.80"},{"date":"2025-09-30","value":"5.27","vol":"10.53"},{"date":"2025-06-30","value":"31.18","vol":"22.82"},{"date":"2025-03-31","value":"6.58","vol":"2.07"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 7.15 | 1.36 | 5.27 | 31.18 | 6.58 |
| 行业 | 5.83 | 30.80 | 10.53 | 22.82 | 2.07 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"1.16","vol":"1.00"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"1.03","vol":"1.03"},{"date":"2025-03-31","value":"","vol":"0.00"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.16 | - | 1.03 | - |
| 行业 | 0.00 | 1.00 | 0.00 | 1.03 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 30/107 ， 43/107。
[{"date":"2026-03-31","value":"2.74","vol":"2.97"},{"date":"2025-12-31","value":"2.64","vol":"2.94"},{"date":"2025-09-30","value":"2.73","vol":"3.09"},{"date":"2025-06-30","value":"2.74","vol":"2.94"},{"date":"2025-03-31","value":"2.90","vol":"3.03"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
2.74 | 2.64 | 2.73 | 2.74 | 2.90 |
| 行业 | 2.97 | 2.94 | 3.09 | 2.94 | 3.03 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"2.16","vol":"2.23"},{"date":"2025-12-31","value":"2.03","vol":"2.15"},{"date":"2025-09-30","value":"2.10","vol":"2.24"},{"date":"2025-06-30","value":"2.12","vol":"2.15"},{"date":"2025-03-31","value":"2.27","vol":"2.24"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
2.16 | 2.03 | 2.10 | 2.12 | 2.27 |
| 行业 | 2.23 | 2.15 | 2.24 | 2.15 | 2.24 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 36/107 ， 40/107。
[{"date":"2026-03-31","value":"25.31","vol":"31.94"},{"date":"2025-12-31","value":"26.02","vol":"32.43"},{"date":"2025-09-30","value":"25.36","vol":"31.59"},{"date":"2025-06-30","value":"25.73","vol":"32.44"},{"date":"2025-03-31","value":"24.81","vol":"31.90"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
25.31 | 26.02 | 25.36 | 25.73 | 24.81 |
| 行业(%) | 31.94 | 32.43 | 31.59 | 32.44 | 31.90 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.34","vol":"0.66"},{"date":"2025-12-31","value":"0.35","vol":"0.67"},{"date":"2025-09-30","value":"0.34","vol":"0.76"},{"date":"2025-06-30","value":"0.35","vol":"0.75"},{"date":"2025-03-31","value":"0.33","vol":"0.74"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.34 | 0.35 | 0.34 | 0.35 | 0.33 |
| 行业(%) | 0.66 | 0.67 | 0.76 | 0.75 | 0.74 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 华创证券 | 2026-04-29 | 增持 | |
| 中国银河 | 2026-04-29 | 买入 | 买入 |
| 华兴证券 | 2026-04-16 | 增持 | |
| 中信证券 | 2026-04-14 | 买入 | |
| 国泰海通证券 | 2026-04-12 | 买入 | |
| 中信建投证券 | 2026-04-11 | 买入 |
机构预测
机构预测该股2026年每股收益与前一年相同，长期投资价值一般。
[{"date":"2022","yellowRectValue":"30.01","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"40.94","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"47.49","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"51.53","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"56.12","blueLineValue":"3.15","type":"YC"}]